Efficacy of serology driven "test and treat strategy" for eradication of H. pylori in patients with rheumatic disease in the Netherlands
The treatment of choice of H. pylori infections is a 7-day triple-therapy with a proton pump inhibitor (PPI) plus amoxicillin and either clarithromycin or metronidazole, depending on local antibiotic resistance rates. The data on efficacy of eradication therapy in a group of rheumatology patients on long-term NSAID therapy are reported here. This study was part of a nationwide, multicenter RCT that took place in 2000-2002 in the Netherlands. Patients who tested positive for H. pylori IgG antibodies were included and randomly assigned to either eradication PPI-triple therapy or placebo. After c... Mehr ...
Verfasser: |
De Leest, HTJI
Steen, KSS
Lems, WF
van de Laar, MAFJ
Huisman, AM (Albert)
Kadir, SW
Houben, HHML
Kostense, PJ
Kuipers, Ernst
Dijkmans, BAC
Debets-ossenkopp, YJ |
Dokumenttyp: |
Artikel |
Erscheinungsdatum: |
2011 |
Reihe/Periodikum: |
De Leest , HTJI , Steen , KSS , Lems , WF , van de Laar , MAFJ , Huisman , AM , Kadir , SW , Houben , HHML , Kostense , PJ , Kuipers , E , Dijkmans , BAC & Debets-ossenkopp , YJ 2011 , ' Efficacy of serology driven "test and treat strategy" for eradication of H. pylori in patients with rheumatic disease in the Netherlands ' , European Journal of Clinical Microbiology & Infectious Diseases , vol. 30 , no. 7 , pp. 903-908 . https://doi.org/10.1007/s10096-011-1174-5 |
Schlagwörter: |
/dk/atira/pure/keywords/researchprograms/AFL001000/EMCMM042001
/ name=EMC MM-04-20-01 |
Sprache: |
unknown |
Permalink: |
https://search.fid-benelux.de/Record/base-29207533 |
Datenquelle: |
BASE;
Originalkatalog |
Powered By: |
BASE |
Link(s) :
|
https://pure.eur.nl/en/publications/86c42dc5-a338-4373-a776-c6b633c5bd39 |